Showing results (21-30 of 41) with videos related to

Sort By:
Pageof 5
International Journal of Chronic Obstructive Pulmonary Disease|February 2, 2018
Relationship between exercise endurance and static hyperinflation in a post hoc analysis of two clinical trials in patients with COPDSally Singh, François Maltais, Lee Tombs, et al.
Respiratory Research|June 4, 2020
Measuring disease activity in COPD: is clinically important deterioration the answer?Dave Singh, Gerard J Criner, Ian Naya, et al.
Pulmonary Therapy|February 7, 2020
Umeclidinium/Vilanterol Versus Tiotropium/Olodaterol in Maintenance-Naïve Patients with Moderate Symptomatic Chronic Obstructive Pulmonary Disease: A Post Hoc AnalysisBernardino Alcázar Navarrete, Isabelle Boucot, Ian Naya, et al.
Journal of Clinical Pharmacology|January 23, 2015
Utility of concentration-effect modeling and simulation in a thorough QT study of losmapimodApril M Barbour, Mindy Magee, Bonnie Shaddinger, et al.
International Journal of Chronic Obstructive Pulmonary Disease|July 1, 2021
Effect of Age on Efficacy and Safety of Fluticasone Furoate/Vilanterol (FF/VI), Umeclidinium (UMEC), and UMEC + FF/VI in Patients with Chronic Obstructive Pulmonary Disease: Analyses of Five Randomized Clinical TrialsNicola A Hanania, Scott Caveney, Tedi Soule, et al.
Respiratory Research|October 29, 2021
Efficacy of umeclidinium/vilanterol according to the degree of reversibility of airflow limitation at screening: a post hoc analysis of the EMAX trialClaus F Vogelmeier, Paul W Jones, Edward M Kerwin, et al.
Advances in Therapy|August 4, 2021
Efficacy and Safety of Umeclidinium/Vilanterol in Current and Former Smokers with COPD: A Prespecified Analysis of The EMAX TrialLeif H Bjermer, Isabelle H Boucot, Claus F Vogelmeier, et al.
International Forum of Allergy & Rhinology|July 3, 2026
Differences in Biologic Clinical Trials for Chronic Rhinosinusitis With Nasal Polyps-Are We Comparing Apples With Oranges?Marjolein Cornet, Peter W Hellings, Martin Desrosiers, et al.
American Journal of Respiratory and Critical Care Medicine|December 16, 2024
Is Disease Stability an Attainable Chronic Obstructive Pulmonary Disease Treatment Goal?Dave Singh, MeiLan K Han, Surya P Bhatt, et al.
Advances in Therapy|November 3, 2017
Comparative Efficacy of Once-Daily Umeclidinium/Vilanterol and Tiotropium/Olodaterol Therapy in Symptomatic Chronic Obstructive Pulmonary Disease: A Randomized StudyGregory J Feldman, Ana R Sousa, David A Lipson, et al.
Pageof 5